Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xeris Biopharma Holdings (XERS) Tax Rate (2022 - 2024)

Xeris Biopharma Holdings (XERS) has disclosed Tax Rate for 3 consecutive years, with 17.44% as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Tax Rate rose 1474.0% year-over-year to 17.44%, compared with a TTM value of 9.41% through Jun 2025, up 1023.0%, and an annual FY2024 reading of 3.97%, up 200.0% over the prior year.
  • Tax Rate was 17.44% for Q3 2024 at Xeris Biopharma Holdings, up from 5.25% in the prior quarter.
  • Across five years, Tax Rate topped out at 17.44% in Q3 2024 and bottomed at 5.25% in Q2 2024.
  • Average Tax Rate over 3 years is 2.48%, with a median of 1.63% recorded in 2023.
  • Peak annual rise in Tax Rate hit 1474bps in 2024, while the deepest fall reached -854bps in 2024.
  • Year by year, Tax Rate stood at 2.55% in 2022, then tumbled by -32bps to 1.73% in 2023, then soared by 907bps to 17.44% in 2024.
  • Business Quant data shows Tax Rate for XERS at 17.44% in Q3 2024, 5.25% in Q2 2024, and 1.64% in Q1 2024.